Philip A. Sharp, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 131,890 shares at $85.00 ($9.3M) on 2014-10-13, disclosed to the SEC on 2014-10-15.
Scheduled sale ($9.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 21,890 | $0 | 0.0% |
| 2 | $85.00 | 110,000 | $9.3M | 100.0% |
| Total | $70.89 avg | 131,890 | $9.3M | 100% |
| Filing → |
| ALNY | SELL | 2018-03-13 | $1.9M | — | Filing → |
| ALNY | SELL | 2017-02-03 | $2.0M | — | Filing → |
| ALNY | SELL | 2017-01-27 | $569K | — | Filing → |